Climb Bio (CLYM) EPS (Basic) (2020 - 2026)

Climb Bio's (CLYM) quarterly EPS (Basic) came in at -$0.68 in Q1 2026, down 114.2% YoY from $4.75 in Q1 2025, and down 56.82% on a QoQ basis from -$0.43 in Q4 2025.

Climb Bio (CLYM) EPS (Basic) (2020 - 2026) Analysis & Trends

Climb Bio (CLYM) has 7 years of EPS (Basic) data on file, last reported at -$0.68 in Q1 2026.

  • Quarterly EPS (Basic) fell 114.2% year-over-year to -$0.68 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.44 (changed 0.29% YoY) and the FY2025 annual result came in at -$1.05, up 50.55% from the prior year.
  • EPS (Basic) eased to -$0.68 in Q1 2026, from -$0.43 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.1 in Q1 2024 to a low of -$1.9 in Q2 2024.
  • A 5-year average of -$0.48 and a median of -$0.32 in 2025 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2024 — EPS (Basic) plunged 550.93% — and 2025, when it soared 93.35%.
  • Tracing CLYM's EPS (Basic) over 5 years: stood at -$0.3 in 2022, then slumped by 209.36% to -$0.91 in 2023, then jumped by 80.34% to -$0.18 in 2024, then slumped by 140.01% to -$0.43 in 2025, then tumbled by 56.82% to -$0.68 in 2026.
  • The last three EPS (Basic) figures came in at -$0.68 (Q1 2026), -$0.43 (Q4 2025), and -$0.21 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Climb Bio 1.24 Bn 1.24 Bn - -1.21

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.21
Mar 31, 2026 -0.68
Dec 31, 2025 -0.43
Sep 30, 2025 -0.21
Jun 30, 2025 -0.13
Mar 31, 2025 -0.32
Dec 31, 2024 -0.18
Sep 30, 2024 -0.15
Jun 30, 2024 -1.90
Mar 31, 2024 -0.10
Dec 31, 2023 -0.91
Sep 30, 2023 -0.19
Jun 30, 2023 -0.29
Mar 31, 2023 -0.94
Dec 31, 2022 -0.30
Sep 30, 2022 -0.37
Jun 30, 2022 -0.56
Mar 31, 2022 -0.50
Dec 31, 2021 -0.86
Sep 30, 2021 -0.70